Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.

Lund N, Pedersen LH, Henriksen TB.

Arch Pediatr Adolesc Med. 2009 Oct;163(10):949-54. doi: 10.1001/archpediatrics.2009.164. Erratum in: Arch Pediatr Adolesc Med. 2009 Dec;163(12):1143.

PMID:
19805715
2.

Antidepressants in pregnancy: a systematic review.

Udechuku A, Nguyen T, Hill R, Szego K.

Aust N Z J Psychiatry. 2010 Nov;44(11):978-96. doi: 10.3109/00048674.2010.507543. Review.

PMID:
21034181
3.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
4.

Safety of selective serotonin reuptake inhibitors in pregnancy.

Alwan S, Friedman JM.

CNS Drugs. 2009;23(6):493-509. doi: 10.2165/00023210-200923060-00004. Review.

PMID:
19480468
5.

Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.

Klinger G, Merlob P.

Isr J Psychiatry Relat Sci. 2008;45(2):107-13. Review.

6.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Eke AC, Saccone G, Berghella V.

BJOG. 2016 Nov;123(12):1900-1907. doi: 10.1111/1471-0528.14144. Epub 2016 May 30. Review.

PMID:
27239775
7.

Fluoxetine during pregnancy: impact on fetal development.

Morrison JL, Riggs KW, Rurak DW.

Reprod Fertil Dev. 2005;17(6):641-50. Review.

PMID:
16263070
8.

Serotonin reuptake inhibitor-induced perinatal complications.

Gentile S.

Paediatr Drugs. 2007;9(2):97-106. Review.

PMID:
17407365
9.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics..

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
10.

Selective serotonin reuptake inhibitors in pregnancy.

Bellissima V, Ververs TF, Visser GH, Gazzolo D.

Curr Med Chem. 2012;19(27):4554-61. Review.

PMID:
22876893
11.

Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).

Ellfolk M, Malm H.

Reprod Toxicol. 2010 Sep;30(2):249-60. doi: 10.1016/j.reprotox.2010.04.015. Epub 2010 May 4. Review.

PMID:
20447455
12.

Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Cantor Sackett J, Weller RA, Weller EB.

Curr Psychiatry Rep. 2009 Jun;11(3):253-7. Review.

PMID:
19470288
13.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
14.

Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review.

Fenger-Grøn J, Thomsen M, Andersen KS, Nielsen RG.

Dan Med Bull. 2011 Sep;58(9):A4303. Review.

PMID:
21893008
15.

[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].

Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.

Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Review. French.

PMID:
20513456
16.

Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.

Sie SD, Wennink JM, van Driel JJ, te Winkel AG, Boer K, Casteelen G, van Weissenbruch MM.

Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F472-6. doi: 10.1136/archdischild-2011-214239. Review. Erratum in: Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F180.

PMID:
23080479
17.

[Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].

Watanabe O.

Seishin Shinkeigaku Zasshi. 2014;116(12):996-1004. Review. Japanese.

PMID:
25823351
18.

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL.

JAMA. 2005 May 18;293(19):2372-83. Review.

PMID:
15900008
19.

[Selective serotonin reuptake inhibitors and pregnancy].

Hassanzadeh T, Pedersen LH, Videbech P.

Ugeskr Laeger. 2014 Feb 3;176(3):236-9. Review. Danish.

PMID:
24629751
20.

The effect of perinatal exposures on the infant: antidepressants and depression.

Hanley GE, Oberlander TF.

Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):37-48. doi: 10.1016/j.bpobgyn.2013.09.001. Epub 2013 Sep 18. Review.

PMID:
24100223

Supplemental Content

Support Center